About Precia Group

Precia’s leadership team is passionate about ensuring that women who participate in clinical trials are valued partners throughout the process. They have decades of experience in women’s health in the US and globally. They have led initiatives to accelerate research efforts to improve reproductive health and address adverse pregnancy outcomes.

The Precia team has significant expertise in standardizing data collection, creation of care plans, maternal and neonate biobanking, global harmonization of maternal cohorts and establishing research efforts in nontraditional clinical settings.

Through the Precia Network, the team is creating new research opportunities for women in the geographic areas where they receive care. They have developed easy-to-use tools to simplify participation (online eligibility screening, etc.). Further, they have been intentional about ensuring that network site Principal Investigators are women.

Donna Russell, MHA

Donna Russell

Donna Russell is co-founder and CEO of Precia Group, a Contract Research Organization founded in 2020 to expand the number of women in studies, especially in early phases. The company is currently focused on women’s reproductive health, pregnancy and menopause but will expand its service areas to include all aspects of women’s health throughout the lifespan.

Prior to Precia Group, Ms. Russell worked in maternal health research, in the US as a Director of Research at Seattle Children’s Research Institute and globally, consulting with the Bill & Melinda Gates Foundation and other major funders and NGOs. She has extensive experience establishing biobanks to support pregnancy cohorts and research networks in the community-setting; and harmonizing collections across multiple networks to enable large-scale multi-omics studies.

Ms. Russell also serves on the board of Valley Medical Center, a community hospital affiliated with the University of Washington and has a deep understanding of how to successfully integrate research into the clinical setting to ensure high-quality, diverse, equitable studies.

Linda S Barnes, DrPH, MHA, RAC

Linda Barnes

A relentlessly passionate advocate for health equity and patient-centricity, Dr. Linda Barnes is an experienced C-suite executive, researcher, and expert in life sciences. She brings more than 25 years of experience in quality and regulatory affairs, research design and operations, and health services delivery.

Dr. Barnes is an implementation expert in cellular therapies, cell and gene therapies, blood transfusion, and biologics. This spans all phases of clinical research and commercialization of novel treatments. She serves on several international standard-setting committees and conducts implementation research in diverse settings around the world. She is President of the Board for Performance Excellence Northwest, a Malcolm Baldrige regional quality organization, and is a credentialed Baldrige Examiner.  She is also certified in Regulatory Affairs (RAC) from the Regulatory Affairs Professional Society.

Dr. Barnes obtained her undergraduate degree in Biology from Whitman College, a Master’s in Health Services Administration from the University of Washington, and a Doctor of Public Health from University of Illinois—Chicago.